Overview

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

Status:
NOT_YET_RECRUITING
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
Primary objective is to is to evaluate the bioequivalence of two formulations
Phase:
PHASE1
Details
Lead Sponsor:
Viatris Inc.
Treatments:
sacubitril
sacubitril and valsartan sodium hydrate drug combination
Valsartan